Please login to the form below

Not currently logged in

Pfizer may sell drug-delivery unit

Pfizer has announced that it may divest its Capsugel business unit, one of the world's leading providers of hard capsules

Pfizer has announced that it may divest its Capsugel business unit, one of the world's leading providers of hard capsules.

Morgan Stanley has been retained to conduct a strategic review of options for the business unit, and Pfizer is aiming to make an announcement of the results by the first quarter of next calendar year.

"Among Pfizer's robust and broad portfolio, Capsugel now represents a unique business, which we believe has strong potential for growth outside of Pfizer,” Cavan Redmond, senior vice president and group president of Pfizer's Diversified Businesses, said in a statement. "This, combined with Capsugel's consistent performance as well as improved financial market conditions, make it a good time to undertake this review."

Capsugel clients include pharmaceutical, consumer healthcare and dietary supplement companies around the world. The business unit had revenues of $740m in 2009. 

Capsugel's products include hard gelatin, liquid-filled, and vegetarian capsules, as well as liquid formations made using its Licaps Drug Delivery System. The business also sells R&D equipment. Capsugel has manufacturing and business facilities around the world, including locations in the US, Europe, Japan and Australia.

6th October 2010


Featured jobs

Subscribe to our email news alerts


Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...